Before it was the target of a federal consent decree, before it posted repeated financial losses and before its stock tanked to less than $1, Invacare Corp. was a powerhouse in its highly regulated ...

Invacare is working to resolve an FDA consent decree over its wheelchair manufacturing--courtesy of Invacare. Invacare ($IVC) has wrapped up the $150.8 million sale ...

Invacare (IVC) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to loss of $0.10 per share a year ago. These figures are ...

Executives looking to return Invacare Corp. (NYSE: IVC) to profitability have ambitious plans for restoring the once-revered manufacturer to its heyday. But with many economic and market factors to ...

The act of walking up to a door and pulling it open is something most people do many times every day without even thinking about it. For those in a wheelchair, however, it’s considerably more ...

Invacare (IVC) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.12 per share a year ago. These figures are adjusted ...

Following acquisition by Rhône, leading mobility and post-acute care businesses combine to drive growth and move health forward together. Rhône, a global private equity firm, has completed the ...

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (“Invacare”)(NYSE:IVC), today announced that the company has completed the sale of its Dynamic Controls subsidiary to Allied Motion Technologies, ...

Invacare Corp. IVC said Wednesday it and two of its U.S.-based subsidiaries have filed for bankruptcy, as it implements a refinancing aimed at reducing net debt by about 65%. The stock is currently ...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet ...